According to Ascendis Pharma 's latest financial reports the company's current EPS (TTM) is -$20.45. In 2022 the company made an earnings per share (EPS) of -$19.53 a decrease over its 2021 EPS that were of -$14.60.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$18.74 | -4.06% |
2022 | -$19.53 | 33.81% |
2021 | -$14.60 | -15.17% |
2020 | -$17.21 | 81.84% |
2019 | -$9.46 | 40.52% |
2018 | -$6.73 | -11.13% |
2017 | -$7.58 | 48.1% |
2016 | -$5.12 | 90.33% |
2015 | -$2.69 | 78.25% |
2014 | -$1.51 |